Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 04, 2018 12:00 ET | Source: Tetra Bio-Pharma Inc.

Tetra Bio-Pharma Receives Health Canada Phase 3 Clinical Trial Approval For Smokable Dried Cannabis Prescription Drug

OTTAWA, ONTARIO--(Marketwired - Feb. 4, 2018) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and...
January 29, 2018 08:00 ET | Source: Tetra Bio-Pharma Inc.

Tetra Bio-Pharma Receives Health Canada Approval for Phase 2 Cannabis Oil Trial in Partnership with Sante Cannabis

OTTAWA, ONTARIO--(Marketwired - Jan. 29, 2018) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and...
January 16, 2018 08:00 ET | Source: Tetra Bio-Pharma Inc.

Tetra Bio-Pharma Receives Approval from Health Canada of its Phase 1 Clinical Trial with PPP005 (Cannabis Oil)

OTTAWA, ONTARIO--(Marketwired - Jan. 16, 2018) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and...
January 02, 2018 08:00 ET | Source: Tetra Bio-Pharma Inc.

Tetra Bio-Pharma Enters into Agreement to Acquire Remaining 20% Interest in Phytopain Pharma Subsidiary

OTTAWA, ONTARIO--(Marketwired - Jan. 2, 2018) - Bio-Pharma Inc. ("Tetra" or the "Corporation") (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development, today...
December 21, 2017 08:00 ET | Source: Tetra Bio-Pharma Inc.

Tetra Bio-Pharma Announces the Signature of a Letter of Intent to Monetize GrowPros and its Late Stage ACMPR Application

OTTAWA, ONTARIO--(Marketwired - Dec. 21, 2017) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and...
December 13, 2017 17:17 ET | Source: Tetra Bio-Pharma Inc.

Tetra Bio-Pharma Reinforces its Development Program by Signing Research & Development Agreement with Constance Therapeutics and Receiving Financial Support from NSERC

OTTAWA, ONTARIO--(Marketwired - Dec. 13, 2017) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and...
December 09, 2017 12:00 ET | Source: Tetra Bio-Pharma Inc.

Tetra Bio-Pharma provides update on status of its Phase 3 Clinical Trial Application of Lead Drug Candidate PPP001

OTTAWA, ONTARIO--(Marketwired - Dec. 9, 2017) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development,...
December 06, 2017 14:01 ET | Source: Tetra Bio-Pharma Inc.

Tetra Bio-Pharma Opens Markets at TSX Listing Ceremony

OTTAWA, ONTARIO--(Marketwired - Dec. 6, 2017) - Editors Note: There is a photo associated with this press release. Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX...
November 28, 2017 17:00 ET | Source: Tetra Bio-Pharma Inc.

Tetra Bio-Pharma accelerates submission of New Drug Application to FDA & Expects to Commercialize Dronabinol XL Tablet Ahead of Schedule(1) in the US

OTTAWA, ONTARIO--(Marketwired - Nov. 28, 2017) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP) (OTCQB:TBPMF), a global leader in cannabinoid-based drug development,...
November 22, 2017 17:02 ET | Source: Tetra Bio-Pharma Inc.

Tetra Bio-Pharma's Business Model and Commercialization Strategy In Line with the Canadian Government's Proposed Approach to the Regulation of Cannabis

OTTAWA, ONTARIO--(Marketwired - Nov. 22, 2017) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and...